Miller I, Scott Perry M, Saneto RP, et al. Cannabidiol (CBD; 10 and 20mg/kg/day) significantly reduces convulsive seizure frequency in children and adolescents with Dravet syndrome (DS): Results of a dose-ranging, multicenter, randomized, doubleblind, placebo-controlled trial (GWPCARE2). AAN 2019, emerging science 006.
Met nieuwe leidraad multimorbiditeit op weg naar toekomstbestendige zorg
okt 2024